Facts & Figures
| Global headquarters | Aubagne, France |
Legal structure | Sartorius Stedim Biotech S.A. is listed on the stock exchange in Paris, France. Sartorius AG holds approximately 74% of the share capital and around 85% of the voting rights of Sartorius Stedim Biotech S.A. |
| Annual sales Revenue 2017 | 1,081.0 million euros |
| - of which EMEA | 43% |
| - of which Americas | 34% |
| - of which Asia | Pacific | 23% |
Underlying EBITDA Underlying EBITDA margin | 294.9 million euros 27.3% |
| Capex ratio | 12,6% |
| Number of employees (as Dec 31, 2017) | 5,100 |